Excellent outcomes can be achieved in children on HAART under routine program conditions in Cambodia. Experience from two hospitals in Siem Reap and Takeo, Cambodia [PDF]
Akao, K +8 more
core +1 more source
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy. [PDF]
Faggiano T +6 more
europepmc +1 more source
Lenacapavir Plus Cabotegravir as Combination Treatment: Real-world Use Cases From the National Clinician Consultation Center. [PDF]
Saberi P +5 more
europepmc +1 more source
Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria. [PDF]
Etuk VP +3 more
europepmc +1 more source
Prevalence of drug resistance mutations and their association with time to virological failure in people living with HIV in Uganda. [PDF]
Ankunda C +6 more
europepmc +1 more source
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]
Cox S +7 more
europepmc +1 more source
A Comparative Evaluation of Four Bioinformatic Tools for Identifying HIV-1 <i>pol</i> Drug Resistance Mutations Using Illumina MiSeq Data. [PDF]
Lee OF, Lee CK.
europepmc +1 more source
HIV-1 drug resistance and genetic clustering among ART-treated individuals with virologic failure in Aksu, China. [PDF]
Dai Z +6 more
europepmc +1 more source
Longitudinal assessment of inflammatory biomarkers among youth with perinatal HIV infection and HIV exposure. [PDF]
Van Dyke RB +8 more
europepmc +1 more source

